The Cumulative Cisplatin Dose Affects the Long-Term Survival Outcomes of Patients with Nasopharyngeal Carcinoma Receiving Concurrent Chemoradiotherapy

The prognostic value of the cumulative cisplatin dose (CCD) remains controversial for patients with nasopharyngeal carcinoma (NPC) receiving only concurrent chemoradiotherapy (CCRT). We retrospectively reviewed 549 consecutive patients with non-metastatic, histologically-proven NPC treated using int...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Hao, Chen, Lei, Li, Wen-Fei, Guo, Rui, Mao, Yan-Ping, Zhang, Yuan, Zhang, Fan, Liu, Li-Zhi, Tian, Li, Lin, Ai-Hua, Sun, Ying, Ma, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829825/
https://www.ncbi.nlm.nih.gov/pubmed/27071833
http://dx.doi.org/10.1038/srep24332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829825/
https://www.ncbi.nlm.nih.gov/pubmed/27071833
http://dx.doi.org/10.1038/srep24332

Ejemplares similares